Literature DB >> 1105232

Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber.

B Mokri, A G Engel.   

Abstract

In seven patients with Duchenne dystrophy, high-resolution phase microscopy demonstrated a population on non-necrotic fibers with one or more focal lesions. The typical lesion was wedge-shaped, with the base resting on the fiber surface. In the electron microscope, the plasma membrane overlying the lesion was either absent or disrupted, while the basement membrane was always preserved. Within the lesion, there were cytoplasmic abnormalities, and in the neighboring fiber region, the myofibrils were usually highly contracted. The structural defect in the plasma membrane suggested that this site was an ineffective cellular barrier. This was confirmed by the frequent ingress of peroxidase-containing extracellular fluid into the lesions. In two control subjects, peroxidase penetration into fibers was seen only rarely and only with other evidence of mechanical injury to the specimen. The findings point to an early and possibly basic abnormality in the plasma membrane of the muscle fiber in Duchenne's dystrophy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105232     DOI: 10.1212/wnl.25.12.1111

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  95 in total

1.  Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation.

Authors:  Davin M Henderson; Ann Lee; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  What does dystrophin do in normal muscle?

Authors:  J B Lansman; A Franco
Journal:  J Muscle Res Cell Motil       Date:  1991-10       Impact factor: 2.698

3.  NO may prompt calcium leakage in dystrophic muscle.

Authors:  James G Tidball; S Armando Villalta
Journal:  Nat Med       Date:  2009-03       Impact factor: 53.440

4.  Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.

Authors:  J H Sher; A Stracher; S A Shafiq; J Hardy-Stashin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

5.  Immunoblot analysis of sarcoplasmic calcium binding proteins in Duchenne muscular dystrophy.

Authors:  I Niebrój-Dobosz; M Lukasiuk
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

6.  Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.

Authors:  T Kumamoto; H Ueyama; S Watanabe; K Yoshioka; T Miike; D E Goll; M Ando; T Tsuda
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice.

Authors:  A J Bakker; S I Head; D A Williams; D G Stephenson
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

8.  Freeze-fracture studies of muscle caveolae in human muscular dystrophy.

Authors:  E Bonilla; K Fischbeck; D L Schotland
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

9.  Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.

Authors:  B P Morgan; C A Sewry; K Siddle; J P Luzio; A K Campbell
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

10.  Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months.

Authors:  B A Valentine; B J Cooper; J F Cummings; A deLahunta
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.